USPUnited States Pharmacopeia

USP is a private, non-profit, science-based standards-setting organisation chartered in 1820 — older than FDA itself. Its standards are not regulations issued by FDA, but they are made enforceable by reference: the Federal Food, Drug, and Cosmetic Act §501(b) declares any drug recognised in USP–NF that fails to meet the official compendial standard 'adulterated', triggering the same FDA enforcement powers as a regulatory violation. Foods and dietary supplements receive parallel treatment under §403 and §201(ff) plus the DSHEA 1994 framework. The result: a USP monograph is functionally a federal quality requirement for any article labelled with the USP designation.

• General Notices — definitions, conventions, abbreviations, atomic weights, basis (anhydrous / as-is) defaults; applies to every monograph unless explicitly overridden.
• General Chapters numbered <1>–<999> — enforceable methods and standards (e.g. <41> Balances, <51> Antimicrobial Effectiveness, <71> Sterility Tests, <85> Bacterial Endotoxins, <232>/<233> Elemental Impurities, <788> Particulates, <797> Sterile Compounding, <800> Hazardous Drugs).
• General Chapters <1000>–<1999> — informational only, not directly enforceable but commonly cited (e.g. <1078> Excipient GMP, <1207> CCIT, <1223> Rapid Microbiology).
• General Chapters <2000>–<2999> — dietary supplements specific.
• Monographs — substance-by-substance and product-by-product specifications (acetaminophen, paracetamol injection, lactose monohydrate). Each monograph defines identity, assay, impurity limits, water content, residue tests and any product-form-specific criteria.
• Reagents, Indicators, Solutions — specifications for the chemicals used in compendial tests.
• Reference Standards — physical materials (USP RS) with assigned values used to calibrate compendial assays.

Proposed standards are drafted by USP Expert Committees and published in Pharmacopeial Forum (PF) for a 90-day public comment period. Comments are reviewed; revisions become official in a USP-NF Supplement or in the next annual edition (publication May, official December). USP–NF has been on a continuous-publication model since 2020, with new official text typically every 6 months. Each revised text carries a Commentary explaining the change rationale; the changes are also flagged in the IRA (Interim Revision Announcement) cycle for safety-driven updates. Manufacturers are expected to comply with the current official version on the official date — earlier compliance is allowed; later is not.

The Pharmacopoeial Discussion Group (PDG) is the trilateral USP / EDQM (Ph.Eur.) / PMRJ (JP) harmonisation forum that has aligned ~40 General Chapters and ~70 excipient monographs since 1990 — bulk-density, particle-size distribution, melting range, residual solvents and many others can now be referenced as harmonised. ICH Q4B then provides the regulator-side recognition that a PDG-harmonised text can be used interchangeably across regions. Where harmonisation has not been achieved, manufacturers still need to demonstrate compliance with the local pharmacopoeia of each marketing region — many CMC dossiers carry parallel USP / Ph.Eur. / JP test results on the same article to support global filings.

Every quantitative compendial assay needs a calibrant of known purity — USP Reference Standards (USP RS) are physical materials supplied by USP with an assigned value. They are typically primary or secondary standards traceable to NIST. A laboratory using a non-USP RS for a USP method must either qualify the alternative against the USP RS or document the deviation under General Notices 5.80.10. Stocking discipline matters — USP RS lots are dated, lots become obsolete on USP's website when new lots release, and using an obsolete RS without re-qualifying against the current lot is a common observation in USP-method audits.

• FCC — Food Chemicals Codex. Identity, strength and purity for food-grade ingredients (flavour compounds, food acids, gums, sweeteners).
• USP Dietary Supplement Compendium — DSC. Aggregated dietary-supplement monographs + General Chapters + supporting documents.
• USP Medicines Compendium — MC (now retired). Replaced by online MC tools and the Pharmacopeial Convention global outreach programme.
• USP–NF Spanish edition — for Latin American markets that reference USP directly.
• Compounding Compendium — USP <795> non-sterile, <797> sterile, <800> hazardous and supporting chapters consolidated for pharmacy compounding.

1. Article labelled 'USP' on the certificate but a non-USP method used for assay — General Notices 6.30 requires that USP labelling means USP method compliance unless an alternative is justified and validated.
2. USP-NF version drift — using a method version that has been superseded by a current-edition revision.
3. Reference standard lot expired or obsolete with no re-qualification.
4. <232>/<233> elemental impurity risk assessment skipped because the article is 'naturally low risk' — risk assessment is required even for low-risk articles.
5. <788> Method 2 (microscopic) used because Method 1 (light obscuration) failed — without justifying the Method-1 failure first.
6. Compounding pharmacy operating under <795> when the work is sterile and <797> applies — wrong chapter selection.
7. Dietary supplement labelled as conforming to a USP monograph that has been changed for purity limit since the label artwork was approved.

• Material master carries the USP monograph reference, the current official version date, and the next official-date forward-watch flag.
• Method master ties each release test to the compendial chapter / monograph clause; method revisions on a new USP edition fire an impact-assessment work item.
• USP RS lot tracking with assigned-value, expiry, and a stop-use when an RS lot is superseded; re-qualification work order auto-created.
• <232>/<233> elemental risk-assessment and <788> particulate test results captured on the CoA against the live monograph limits.
• Compounding-pharmacy customers run on the <795>/<797>/<800> templates with the Category 1/2/3 BUD tables built in (per the 2023 <797> revision).
• When USP–NF publishes a Supplement or IRA, a regulatory-intelligence work item is created listing impacted monographs and methods — the change does not silently slip through.